| ISIN | CH0389550945 |
|---|---|
| Valor Number | 38955094 |
| Bloomberg Global ID | UBSSPLW SW |
| Fund Name | UBS (CH) Investment Fund - Equities Switzerland Leader Index A-acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Asset Class | Bonds |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | ... |
| Peculiarities |
| Current Price * | 160.37 CHF | 21.11.2025 |
|---|---|---|
| Previous Price * | 159.64 CHF | 20.11.2025 |
| 52 Week High * | 164.53 CHF | 12.11.2025 |
| 52 Week Low * | 135.84 CHF | 09.04.2025 |
| NAV * | 160.37 CHF | 21.11.2025 |
| Issue Price * | 160.37 CHF | 21.11.2025 |
| Redemption Price * | 160.37 CHF | 21.11.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 2,105,615,540 | |
| Unit/Share Assets *** | 128,301,975 | |
| Trading Information SIX | ||
| YTD Performance | +8.94% |
31.12.2024 - 21.11.2025
31.12.2024 21.11.2025 |
|---|---|---|
| 1 month | -0.38% |
21.10.2025 - 21.11.2025
21.10.2025 21.11.2025 |
| 3 months | +0.99% |
21.08.2025 - 21.11.2025
21.08.2025 21.11.2025 |
| 6 months | +0.77% |
21.05.2025 - 21.11.2025
21.05.2025 21.11.2025 |
| 1 year | +9.29% |
21.11.2024 - 21.11.2025
21.11.2024 21.11.2025 |
| 2 years | +25.50% |
21.11.2023 - 21.11.2025
21.11.2023 21.11.2025 |
| 3 years | +29.91% |
21.11.2022 - 21.11.2025
21.11.2022 21.11.2025 |
| 5 years | +41.10% |
23.11.2020 - 21.11.2025
23.11.2020 21.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nestle SA | 9.40% | |
|---|---|---|
| Novartis AG Registered Shares | 8.78% | |
| Roche Holding AG | 8.69% | |
| UBS Group AG Registered Shares | 8.58% | |
| Compagnie Financiere Richemont SA Class A | 4.80% | |
| ABB Ltd | 4.74% | |
| Swiss Re AG | 4.71% | |
| Zurich Insurance Group AG | 4.42% | |
| Lonza Group Ltd | 4.26% | |
| Holcim Ltd | 4.13% | |
| Last data update | 31.10.2025 | |
| TER | 0.19% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.30% |
| Ongoing Charges *** | 0.21% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |